Answers are grounded in this paper and cite their sources.
Dallas, Texas From the Department of Plastic Surgery, University of Texas Southwestern Medical Center. Received for publication December 17, 2010; accepted December 17, 2010. Disclosure:Rod J. Rohrich, M.D., declares he is the recipient of research grant funds received by the University of Texas Southwestern Medical Center from Medicis, Contura, Mentor (dermal fillers or botulinum toxin type A studies), and Baxter (fibrin sealant study). This supplement in its entirety is jointly published by the Journal of the American Academy of Dermatology and Plastic and Reconstructive Surgery. Citation of the articles in PRS follows this format: Rohrich RJ, Hanke CW. Facial Soft-Tissue Fillers: Assessing the State-of-the-Science Conference—Proceedings Report. Plast Reconstr Surg. 2011;127(Suppl 2):9S–21S. Citation of the articles in JAAD follows this format: Hanke CW, Rohrich RJ, Busso M, Carruthers A, Carruthers J, Fagien S, et al. Facial Soft-Tissue Fillers: Assessing the State-of-the-Science Conference—Proceedings Report. J Am Acad Dermatol 2011;64(Suppl):S53–S65. Rod J. Rohrich, M.D., Editor-in-Chief, Plastic and Reconstructive Surgery, 5959 Harry Hines Boulevard, P.O. Box 1, Suite 300, Dallas, Texas 75390-8820, [email protected]
No takes yet. Share an insight, caveat, or question.
Rod J. Rohrich (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: